|
|
| | Takeda103A Basic information |
| Product Name: | Takeda103A | | Synonyms: | Takeda103A;Benzamide, N-[(2,6-difluorophenyl)methyl]-3-[[[4-propyl-5-(4-pyrimidinyl)-4H-1,2,4-triazol-3-yl]methyl]amino]-;CMPD103A;CMPD-103A;Inhibitor,inhibit,heart failure,GRK2,Takeda103A,GPCRs;N-(2,6-Difluorobenzyl)-3-(((4-propyl-5-(pyrimidin-4-yl)-4H-1,2,4-triazol-3-yl)methyl)amino)benzamide;N-[(2,6-difluorophenyl)methyl]-3-({[4-propyl-5-(pyrimidin-4-yl)-4H-1,2,4-triazol-3-yl]methyl}amino)benzamide | | CAS: | 865609-72-9 | | MF: | C24H23F2N7O | | MW: | 463.48 | | EINECS: | | | Product Categories: | | | Mol File: | 865609-72-9.mol |  |
| | Takeda103A Chemical Properties |
| storage temp. | Store at -20°C | | form | Solid | | color | White to off-white |
| | Takeda103A Usage And Synthesis |
| Uses | Takeda 103A novel potent inhibitor of the GRK2-- dependent bovine tubulin oxidation. |
| | Takeda103A Preparation Products And Raw materials |
|